Retour
44
Fourchette du Jour
17,20 €
18,36 €
Fourchette 52 Semaines
16,76 €
28,75 €
Volume
1 088 337
Moyenne 50J / 200J
21,58 €
/
22,49 €
Clôture Précédente
18,05 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 24,8 | 0,2 |
| P/B | 2,8 | 3,0 |
| ROE % | 12,5 | 3,6 |
| Net Margin % | 4,5 | 3,8 |
| Rev Growth 5Y % | 26,7 | 9,7 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
30,80 €
+73.5%
Low: 28,00 €
High: 35,00 €
P/E Prévisionnel
15,18
BPA Prévisionnel
1,17 €
Croissance BPA (est.)
+0,0%
CA Est.
1,38B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,64 €
1,60 € – 1,68 €
|
1,68B | 1 |
| FY2029 |
1,85 €
1,80 € – 1,90 €
|
1,69B | 1 |
| FY2028 |
1,73 €
1,39 € – 1,96 €
|
1,59B | 3 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-26 | 0,38 € | 0,48 € | +26,3% |
| 2025-11-06 | 0,39 € | 0,45 € | +15,4% |
| 2025-08-07 | 0,44 € | 0,48 € | +9,1% |
| 2025-05-08 | 0,45 € | 0,48 € | +6,7% |
| 2025-02-27 | 0,37 € | 0,42 € | +13,5% |
| 2024-11-12 | 0,37 € | 0,40 € | +8,1% |
| 2024-08-06 | 0,36 € | 0,43 € | +19,4% |
| 2024-05-09 | 0,14 € | 0,39 € | +178,6% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 26,67% annually over 5 years — strong growth
ROE of 12,48% — decent returns on equity
Debt/Equity of 0,05 — conservative balance sheet
Generating 191,78M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 16,27%
Cash machine — converts 327,72% of earnings into free cash flow
Croissance
Revenue Growth (5Y)
26,67%
Revenue (1Y)10,40%
Earnings (1Y)7,70%
FCF Growth (3Y)1,77%
Qualité
Return on Equity
12,48%
ROIC11,84%
Net Margin4,54%
Op. Margin6,62%
Sécurité
Debt / Equity
0,05
Current Ratio2,73
Interest Coverage0,00
Valorisation
P/E Ratio
24,84
Forward P/E15,18
P/B Ratio2,82
EV/EBITDA16,01
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 10,40% | Revenue Growth (3Y) | 8,80% |
| Earnings Growth (1Y) | 7,70% | Earnings Growth (3Y) | -2,88% |
| Revenue Growth (5Y) | 26,67% | Earnings Growth (5Y) | -2,88% |
| Profitability | |||
| Revenue (TTM) | 1,29B | Net Income (TTM) | 58,52M |
| ROE | 12,48% | ROA | 7,88% |
| Gross Margin | 23,63% | Operating Margin | 6,62% |
| Net Margin | 4,54% | Free Cash Flow (TTM) | 191,78M |
| ROIC | 11,84% | FCF Growth (3Y) | 1,77% |
| Safety | |||
| Debt / Equity | 0,05 | Current Ratio | 2,73 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 24,84 | Forward P/E | 15,18 |
| P/B Ratio | 2,82 | P/S Ratio | 1,13 |
| PEG Ratio | 2,45 | Forward PEG | N/A |
| EV/EBITDA | 16,01 | Fwd EV/EBITDA | 9,72 |
| Forward P/S | 1,06 | Fwd Earnings Yield | 6,59% |
| FCF Yield | 13,19% | ||
| Market Cap | 1,45B | Enterprise Value | 1,37B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,29B | 1,17B | 1,09B | 786,91M | 500,62M |
| Net Income | 58,52M | 54,34M | 62,04M | 30,36M | 65,77M |
| EPS (Diluted) | 0,65 | 0,57 | 0,62 | 0,30 | 0,66 |
| Gross Profit | 304,48M | 253,36M | 238,80M | 167,33M | 112,14M |
| Operating Income | 85,28M | 67,46M | 62,18M | 23,34M | 32,34M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 742,44M | 607,10M | 756,62M | 542,99M | 358,07M |
| Total Liabilities | 226,39M | 185,04M | 203,19M | 166,02M | 106,24M |
| Shareholders' Equity | 516,04M | 422,06M | 553,43M | 376,97M | 251,82M |
| Total Debt | 24,00M | 19,27M | 19,39M | 7,71M | 8,65M |
| Cash & Equivalents | 112,24M | 162,31M | 97,30M | 120,08M | 91,41M |
| Current Assets | 551,78M | 472,72M | 640,41M | 433,86M | 258,54M |
| Current Liabilities | 202,39M | 168,63M | 185,95M | 159,54M | 98,82M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#536 of 1049
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026